Pharmaron Beijing Co Ltd
SZSE:300759
Pharmaron Beijing Co Ltd
Revenue
Pharmaron Beijing Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Revenue
¥11.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Revenue
¥40.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Revenue
¥17B
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Revenue
¥7.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
26%
|
CAGR 10-Years
36%
|
|
Genscript Biotech Corp
HKEX:1548
|
Revenue
$839.5m
|
CAGR 3-Years
29%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Revenue
¥990.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pharmaron Beijing Co Ltd's Revenue?
Revenue
11.5B
CNY
Based on the financial report for Dec 31, 2023, Pharmaron Beijing Co Ltd's Revenue amounts to 11.5B CNY.
What is Pharmaron Beijing Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
32%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Pharmaron Beijing Co Ltd have been 31% over the past three years , 32% over the past five years .